MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Deceleration capacity of heart rate indicates autonomic dysfunction in patients with PSP

    V. Ries, N. Mix, D. Vadasz, A. Bauer, W.H. Oertel (Marburg, Germany)

    Objective: The study focuses on assessing cardiovascular autonomic dysfunction in patients with different atypical Parkinsonian syndromes compared to healthy controls using the heart rate deceleration…
  • 2016 International Congress

    Multimodal voxel-based analysis of the infratentorial brain region in Richardson’s syndrome, progressive supranuclear palsy-parkinsonism, Parkinson variant of multiple system atrophy and Parkinson’s disease

    M. Seki, C. Müller, E. Reiter, M. Nocker, M. Schocke, E. Gizewski, C. Kremser, G. Wenning, W. Poewe, K. Seppi, C. Scherfler (Innsbruck, Austria)

    Objective: Voxel-based analysis was applied to MRI parameters of iron content (transverse relaxation rate, R2*), microstructural integrity including mean diffusivity (MD) and fractional anisotropy (FA)…
  • 2016 International Congress

    Spinal fluid biomarkers for multiple system atrophy – A pilot study

    W. Singer, A. Schmeichel, D.M. Goldstein, J.D. Schmelzer, A.D. Zeller, T.L. Gehrking, P.A. Low (Rochester, MN, USA)

    Objective: To evaluate a comprehensive panel of cerebral spinal fluid (CSF) markers in multiple system atrophy (MSA) to define those with potential as future disease…
  • 2016 International Congress

    Is continuous twenty four hour blood pressure monitoring a suitable tool in evaluating sleep disturbances in Parkinson’s disease?

    M. Hahne, D. Hartmann, C. Thomopoulos, A. Ramih, M. Esther, Y. Guangji, G. Bernd, W. Dirk, R. Heinz, J. Wolfgang (Bad Neustadt, Germany)

    Objective: To compare blood pressure (BP) changes in nighttime by continuous twenty four hour blood pressure monitoring (RR) as a postulated tool to describe sleep…
  • 2016 International Congress

    Double-blind, placebo-controlled trial of a fermented milk containing multiple probiotic strains and prebiotic fiber for constipation associated with Parkinson’s disease

    E. Cereda, C. Pacchetti, C. Bolliri, E. Cassani, L. Iorio, C. Pusani, G. Pinelli, G. Privitera, I. Cesari, S.A. Faierman, R. Caccialanza, G. Pezzoli, M. Barichella (Pavia, Italy)

    Objective: Our objective was to evaluate the efficacy of probiotics and prebiotics in Parkinson's disease (PD) patients with constipation. Background: Few treatment options have been…
  • 2016 International Congress

    RBD increase non-motor symptom in Parkinson’s disease

    Y. Wu, Y. Liu, X. Zhu, X. Zhang, S. Kuo, W.G. Ondo (Shanghai, People's Republic of China)

    Objective: To investigate the relationship between the RBD and other non-motor symptoms in Parkinson's disase. Background: Rapid eye movement sleep behavior disorder (RBD) is frequent…
  • 2016 International Congress

    Irritable bowel syndrome is more prevalent than functional constipation in Parkinson’s disease: Clinical spectrum and changes in gut microbiota

    T. Mertsalmi, V. Aho, P.A.B. Pereira, L. Paulin, E. Pekkonen, P. Auvinen, F. Scheperjans (Helsinki, Finland)

    Objective: To assess distal functional gastrointestinal (GI) symptoms and their connection to fecal microbiota (FM) in Parkinson (PD) patients. Background: The majority of PD patients…
  • 2016 International Congress

    Anosmia predicts development of more severe motor symptoms including freezing of gait and impaired balance at 2 year follow-up in PD

    N.I. Bohnen, J. Haugen, V. Kotagal, K.A. Frey, R.L. Albin, M.L.T.M. Muller (Ann Arbor, MI, USA)

    Objective: To investigate the relationship between baseline anosmia and 2-yr interval development of motor impairments in Parkinson's disease (PD). Background: More severe olfactory deficits have…
  • 2016 International Congress

    Modulation and mechanism for the neuroprotective effects of 17-beta-estradiol: Relevance to depressive symptoms in Parkinson’s disease

    P. Kumar, N. Baquer (New Delhi, India)

    Objective: The objective of this study was to investigate neuroprotective potential of 17β estradiol (E2) treatment on the activities of acetylcholinesterase and monoamine oxidase, membrane…
  • 2016 International Congress

    Usefulness of total neuropathy score revised as a screening tool of peripheral neuropathy in patients with Parkinson’s disease

    P.W. Ko, J.S. Park, K. Kang, H.W. Lee (Daegu, Korea)

    Objective: To evaluate (1) prevalence of peripheral neuropathy and (2) usefulness of known neuropathy scores in patients with Parkinson's disease (PD). Background: Peripheral neuropathy has…
  • « Previous Page
  • 1
  • …
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Life expectancy with and without Parkinson’s disease in the general population
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley